New Accelerated Approval Withdrawal Process More Streamlined, Marks Says

 
• By Derrick Gingery
multiple myeloma
Pepaxto is the third product that used accelerated approval to gain market entry and then be withdrawn through FDA regulation. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards